Partnerships and grants
We want to find better ways to support people suffering with mental health challenges, and we believe we’re onto something important.
Partnerships and grants
Collaboration is key to developing a new approach to mental health, and this is why we are bringing together health innovators for the benefit of patients.
The Aquilino Cancer Center is a specialist cancer center at Adventist Healthcare Shady Grove Medical Center in Maryland, US. We have provided support, training and funding for their investigator-initiated study using our COMP360 psilocybin therapy in cancer patients with depression.
Depression and Bipolar Support Alliance. COMPASS is driven by direct and personal experience of mental health challenges such as depression. We believe that patients’ voices need to be heard and we want to transform the patient experience in mental health care. This is why we support the Depression and Bipolar Support Alliance (DBSA), a leading organization focusing on mood disorders including depression and bipolar disorder in the United States. Specifically, we support the DBSA’s work in learning more about the experiences of people living with depression.
The Grady Trauma Project is a group of investigators studying civilian trauma, based at Grady Memorial Hospital and Emory University School of Medicine in Atlanta, Georgia. The project focuses on Post-Traumatic Stress Disorder and the clinical and physiological implications of trauma exposure. COMPASS Pathways is supporting the group in research to investigate perceptions of psychedelics in underserved groups, particularly racial and ethnic minorities, to help inform best practices.
Mindstrong Health delivers digital biomarkers of brain health. Its scientifically validated technology uses content-free, human-smartphone interactions to measure cognition and mood. We are working with Mindstrong Health on our treatment-resistant depression clinical trial to assess digital biomarkers as exploratory clinical endpoints.
We seek to partner with mental health providers to ensure evidence-based innovation that is offered safely and with appropriate supportive care to as many patients as possible. This is why we are partnering with the National Council for Mental Wellbeing, a unifying voice of America’s health care organisations that deliver mental health and addictions treatment and services.
The Psychiatry Consortium is a strategic collaboration of leading medical research charities and pharmaceutical companies focusing on the challenge of identifying and validating novel drug targets to address the unmet therapeutic needs of the people living with mental health conditions. COMPASS Pathways joined as a consortium member in November 2020.
We are on the American Psychiatric Association Foundation’s Corporate Advisory Council. The APA Foundation aims to address critical mental health needs through community-based programmes, fellowships, awards and grants. Their Corporate Advisory Council unites diverse stakeholders around advancing mental health in all areas of our communities.
AHIP is a US national association whose members provide health care coverage, services, and solutions to hundreds of millions of Americans every day. It is committed to market-based solutions and public-private partnerships that make health care better and coverage more affordable and accessible for everyone. We are proud to partner with AHIP, in recognition that an important aspect of accelerating patient access to innovation in mental health is affordability.
We are working with the Global Alliance of Mental Illness Advocacy Networks-Europe (GAMIAN-Europe), a patient-driven, pan-European organisation that represents and advocates for the interests and rights of individuals experiencing mental ill-health. We are supporting GAMIAN-Europe’s Quality of Life project, which aims to understand and raise awareness of patients’ perspectives on what impacts on and improves their quality of life, and share approaches for managing a better quality of life.